Publications in: “17/05/2019”

A therapeutic strategy for all pneumonia patients: a 3-year prospective multicenter cohort study using risk factors for multiresistant pathogens to select initial empiric therapy

Pneumonia empiric therapy is currently based on the site of acquisition (community or hospital), but could be chosen, based on risk factors for multiresistant (MDR) pathogens. The authors applied an algorithm to 1,089 patients using MDR risks (antibiotic use on the last 180 days before pneumonia diagnosis, poor functional state, hospitalized patient for more than 2 days within the last 90 days before pneumonia diagnosis, pneumonia occurring for 5 or more days after admission to acute care hospital, hemodialysis and […]